Cancer CareClinical Trials
Reid Cancer Center is currently involved with oncology clinical trials through the Dayton Clinical Oncology Program, which is a National Cancer Institute funded program.
You do not have to travel to Dayton to participate in a clinical trial - all of your care will be done right here at Reid.
We are currently involved in trials:
-
Phase II trials: Continues to test the safety of the drug, and begins to evaluate how well the new drug works. Usually focus on a particular type of cancer.
Phase III trials: These test a new drug, a new combination of drugs, or a new procedure in comparison to the current standard. A participant will usually be assigned to the standard group or the new group at randomization. Often enroll large numbers of people.
Phase IV trials: These trials test new drugs approved by the FDA. The drug is tested in several hundreds or thousands of patients. This allows for better research on short-lived and long-lasting side effects and safety. For instance, some rare side effects may only be found in large groups of people. Doctors can also learn more about how well the drug works and if it's helpful when used with other treatments
There are also clinical trials available that look at treating
the symptoms and side effects of cancer treatment.
For more information, call: Amy Thompson, (765) 983-3000
ext. 2395